Summary
Broadly neutralizing antibodies are more evolutionarily distant from their germline precursors than antibodies that target the same epitope in a single variant (1,2). These mutations sometimes include indels. These mutations are still defined by a lack of evidence for epistasis.
1.
Kirby MB, Petersen BM, Faris JG, Kells SP, Sprenger KG, Whitehead TA. Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive. Proceedings of the National Academy of Sciences. 2025;122(4). Available from: https://doi.org/10.1073/pnas.2412787122
2.
Ovchinnikov V, Louveau JE, Barton JP, Karplus M, Chakraborty AK. Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies. eLife. 2018;7. Available from: https://doi.org/10.7554/elife.33038